Category | Insight journal

New report: Global Autoimmune Disease Partnering 2010-2015

Posted on 05 March 2015

The Global Autoimmune Disease Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies

Tags:

More merger talks for Claris Lifesciences: Pfizer, Amneal, Novartis…

Posted on 18 February 2015

India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the

Tags: , , , ,

Novartis eyes for more pharma deals in Israel

Posted on 17 February 2015

Novartis , the world’s biggest pharmaceutical (big pharma) company, recently increased its interest in Israel to sign pharma deals. For a long time, the company was active in marketing and clinical trials in Israel, and now it is involved in investment as well.

Tags: , , ,

Charles River Laboratories hunts for M&A

Posted on 17 February 2015

M&A hunt: Speaking at the Leerink Swann Global Healthcare Conference last week, James Foster, chief executive officer of Charles River Laboratories, indicated the company was actively looking for merger and acquisition targets in 2015.

Tags: ,

M&A news: who will win the bidding race?

Posted on 16 February 2015

M&A news: The Canadian pharma company Valeant Pharmaceuticals is rumoured to be raising money to make a bid for specialty drugmaker Salix Pharmaceuticals, according to Bloomberg, which cites people familiar with the matter.

Tags: , , , ,

Merger news : Actavis eyes $3 billion bid for Almirall

Posted on 23 December 2014

Merger news: Rumors that Ireland-based Actavis  is still looking to buy up a company or two continue with speculation that it is considering Spanish drugmaker Almirall SA. Actavis, which is domiciled in Ireland, but operates out of Parsippany, N.J. was also earlier rumored to be interested in buying GI drugmaker Salix Pharmaceuticals and Omega Pharma NV.

Tags: ,

Chugai Pharmaceutical: Partnering activity 2009-2014

Posted on 15 December 2014

Chugai Pharmaceutical, headquartered in Japan, is a subsidiary of Roche, having operations in Asia, Europe and North America. This company is now ranked as a Top 50 Pharma company by Current Partnering.

Tags: , ,

Aspen Pharma: Partnering activity 2009-2014

Posted on 08 December 2014

Aspen Pharma, a global branded and generics pharmaceutical manufacturer, has found a place in the top 50 big pharma companies listed by Current Partnering.

Tags: , ,

Biotech rumor mill : Helix BioPharma in the spotlight

Posted on 08 December 2014

Biotech rumor mill: Helix BioPharma Corp. announced Friday that it has begun “a comprehensive exploration of growth opportunities,” code that most of the biotech market has taken to mean the company has a shopping list of potential acquisitions and will be buying snap-on targets soon.

Tags: , ,

Chugai Pharmaceutical Ltd – Japan’s number one biopharmaceutical company

Posted on 05 December 2014

Chugai Pharmaceutical manufactures, sells, imports and exports pharmaceuticals and has become the leading biopharmaceutical company in Japan.

Tags: , ,

cpbannerad300x150new1gif
stem-celljpg
poddcp15300-150jpg
RSS FeedLinked InTwitter

Latest Tweets

cpbannerad300x150new2gif
biotech-china-300x150jpg
diabetesjpg